IL10 and cancer: The expansion of IL-10+, TIM-1+, PD-1+ and GrB+ Bregs has been correlated with progressive disease stage and poorer prognosis in patients, highlighting the intricate functional roles of these cells in cancer pathogenesis, prognosis and outcomes.